Lonza Group AG (OTCMKTS:LZAGY – Free Report) – William Blair issued their FY2026 EPS estimates for shares of Lonza Group in a report issued on Wednesday, January 29th. William Blair analyst M. Smock anticipates that the company will post earnings per share of $2.03 for the year. The consensus estimate for Lonza Group’s current full-year earnings is $1.88 per share.
A number of other brokerages have also recently weighed in on LZAGY. The Goldman Sachs Group raised shares of Lonza Group to a “strong-buy” rating in a research report on Wednesday, October 9th. Redburn Atlantic raised Lonza Group to a “strong-buy” rating in a research report on Wednesday, November 27th.
Lonza Group Trading Up 3.2 %
Shares of LZAGY stock opened at $65.41 on Monday. The company has a 50 day moving average price of $60.47 and a 200 day moving average price of $62.08. Lonza Group has a one year low of $49.42 and a one year high of $67.00. The company has a quick ratio of 1.38, a current ratio of 2.04 and a debt-to-equity ratio of 0.39.
About Lonza Group
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Featured Stories
- Five stocks we like better than Lonza Group
- 3 Grocery Stocks That Are Proving They Are Still Essential
- How to Invest in Small Cap Stocks
- How to Profit From Value Investing
- These Are the Dividend Stocks Insiders Bought in January
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
